Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched" or the "Company"), a life sciences company dedicated to developing and commercializing products derived from the Amanita Muscaria mushroom, is pleased to announce a key commercial milestone for its newest product, Calmer. The Company has officially sold out of its initial production run following strong early demand and positive consumer feedback.Newest Product: CalmerTo view an en ...

Core Insights - Psyched Wellness Ltd. has launched a new product called Calmer, which is a more potent version of its existing product Calm, offering twice the potency [1][2] - The company has also improved the flavor profile of Calm, reducing the mushroom taste while maintaining its potency [2] - A Black Friday promotion is currently being offered, providing a 40% discount on all products (excluding merchandise) until December 1, 2025 [2] Product Development - Calmer is developed based on feedback from monthly subscribers who requested a stronger version of Calm [2] - The company has concentrated its proprietary extract AME-1 without compromising the product's potency or consumer experience [2] Market Expansion - Psyched Wellness is actively expanding its route-to-market partnerships across Canada and the United States [2][3] - The company encourages interested distributors or retailers to reach out for potential partnerships [3] Company Background - Psyched Wellness Ltd. specializes in dietary supplements derived from the Amanita Muscaria mushroom, focusing on research and production of consumer packaged goods [4]